Surgeons at UCHealth Anschutz Cancer Pavilion in Aurora are using new technology to identify cancer cells they normally would’ve missed.
Pafolacianine, also known by the brand name CYTALUX, is a molecule that binds to cancer cells and lights them up with fluorescent markers, making them glow. The U.S. Food and Drug Administration (FDA) has approved it for use in the lungs and ovaries.
Patients get an infusion hours before surgery where doctors use a robot a camera and a near-infrared light to make that fluorescent light visible…